NO20021430D0 - Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometerielt vev, kronisk bekkensmerte og tetteeggledere - Google Patents

Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometerielt vev, kronisk bekkensmerte og tetteeggledere

Info

Publication number
NO20021430D0
NO20021430D0 NO20021430A NO20021430A NO20021430D0 NO 20021430 D0 NO20021430 D0 NO 20021430D0 NO 20021430 A NO20021430 A NO 20021430A NO 20021430 A NO20021430 A NO 20021430A NO 20021430 D0 NO20021430 D0 NO 20021430D0
Authority
NO
Norway
Prior art keywords
congenital
vein
procedure
pelvic pain
chronic pelvic
Prior art date
Application number
NO20021430A
Other languages
English (en)
Other versions
NO20021430L (no
NO331198B1 (no
Inventor
Juergen Engel
Hilde Riethmueller-Winzen
Ricardo Felberbaum
Klaus Diedrich
Wolfgang KUEPKER
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20021430D0 publication Critical patent/NO20021430D0/no
Publication of NO20021430L publication Critical patent/NO20021430L/no
Publication of NO331198B1 publication Critical patent/NO331198B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20021430A 1999-09-23 2002-03-21 Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon NO331198B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15547899P 1999-09-23 1999-09-23
PCT/EP2000/009212 WO2001021194A2 (en) 1999-09-23 2000-09-20 Method for the therapeutic management of endometriosis and fallopian tube obstruction

Publications (3)

Publication Number Publication Date
NO20021430D0 true NO20021430D0 (no) 2002-03-21
NO20021430L NO20021430L (no) 2002-05-07
NO331198B1 NO331198B1 (no) 2011-10-31

Family

ID=22555601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021430A NO331198B1 (no) 1999-09-23 2002-03-21 Anvendelse av LHRH-antagonist for fremstilling av et medikament til terapeutisk styring av ekstrauterin proliferering av endometrievev, kronisk bekkensmerte og egglederobstruksjon

Country Status (22)

Country Link
EP (1) EP1214086A2 (no)
JP (2) JP2003509467A (no)
KR (1) KR100772852B1 (no)
CN (2) CN1376070A (no)
AU (1) AU769482B2 (no)
BG (1) BG66128B1 (no)
BR (1) BR0014198A (no)
CA (1) CA2383510A1 (no)
HK (1) HK1049117A1 (no)
HU (1) HUP0202741A3 (no)
IL (1) IL148185A0 (no)
MX (1) MXPA02002436A (no)
NO (1) NO331198B1 (no)
NZ (1) NZ534836A (no)
PL (1) PL201898B1 (no)
RU (1) RU2255759C2 (no)
SK (1) SK3752002A3 (no)
TR (1) TR200200738T2 (no)
TW (1) TWI267373B (no)
UA (1) UA73956C2 (no)
WO (1) WO2001021194A2 (no)
ZA (1) ZA200201374B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
KR101749310B1 (ko) 2008-01-24 2017-06-21 에스퍼란스 파마슈티컬스, 인코포레이티드 용해 도메인 융합 구성물 및 이를 제조하고 사용하는 방법
CA2750582A1 (en) * 2009-01-22 2010-07-29 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
DK2914633T3 (da) 2012-10-30 2022-03-14 Esperance Pharmaceuticals Inc Antistof/lægemiddel-konjugater og anvendelsesfremgangsmåder
JP6159870B2 (ja) 2013-03-15 2017-07-05 アッヴィ・インコーポレイテッド 月経出血過多および子宮類線維腫の処置に使用するための組成物
CN112261942A (zh) 2018-04-19 2021-01-22 艾伯维公司 治疗重度月经出血的方法
EP3560555A1 (en) * 2018-04-26 2019-10-30 LifeArc A composition for treating one or more estrogen related diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
SE9301606D0 (sv) * 1993-05-07 1993-05-07 Per-Christer Oden Composition for the treatment of impaired hair growth
CN1137722C (zh) * 1994-07-22 2004-02-11 汉普顿路医学院 为长期治疗方案确立基础(tonic)卵巢雌激素分泌
US5658884A (en) * 1994-07-22 1997-08-19 The Medical College Of Hampton Roads Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens
DE19513662A1 (de) * 1995-04-08 1996-10-10 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption
DE19604231A1 (de) * 1996-01-29 1997-07-31 Schering Ag Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen
CN1228708A (zh) * 1996-09-04 1999-09-15 有限会社多特 经口给药用含肽药物组合物
CA2292605A1 (en) * 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung

Also Published As

Publication number Publication date
RU2255759C2 (ru) 2005-07-10
SK3752002A3 (en) 2003-06-03
NO20021430L (no) 2002-05-07
AU769482B2 (en) 2004-01-29
HUP0202741A2 (hu) 2003-01-28
TR200200738T2 (tr) 2002-08-21
NZ534836A (en) 2007-07-27
MXPA02002436A (es) 2003-02-12
IL148185A0 (en) 2002-09-12
JP2012051920A (ja) 2012-03-15
BG66128B1 (bg) 2011-06-30
BG106584A (bg) 2003-02-28
JP2003509467A (ja) 2003-03-11
TWI267373B (en) 2006-12-01
KR20020035879A (ko) 2002-05-15
HK1049117A1 (zh) 2003-05-02
BR0014198A (pt) 2002-05-21
PL353244A1 (en) 2003-11-03
HUP0202741A3 (en) 2003-12-29
CN101045155A (zh) 2007-10-03
UA73956C2 (en) 2005-10-17
EP1214086A2 (en) 2002-06-19
AU7779200A (en) 2001-04-24
KR100772852B1 (ko) 2007-11-02
NO331198B1 (no) 2011-10-31
PL201898B1 (pl) 2009-05-29
WO2001021194A2 (en) 2001-03-29
CN1376070A (zh) 2002-10-23
WO2001021194A3 (en) 2002-03-14
ZA200201374B (en) 2002-10-30
CA2383510A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
NO20020635D0 (no) Proteinpolymeriseringsinhibitorer og fremgangsmåter for anvendelse
EE200100603A (et) Inimese refraktaarsete kasvajate ravi epidermaalse kasvufaktori retseptori antagonistidega
AU2002351397A1 (en) Systems and methods using vasoconstriction for improved thermal treatment of tissues
AU2002234021A1 (en) Method and device for the treatment of vulnerable tissue site
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
NO20011594D0 (no) Massasjevibrator for lindring av smerter og lidelser
NO20021094D0 (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
NO20021430D0 (no) Fremgangsmåte for terapeutisk forvaltning av ekstrauterin proliferering av endometerielt vev, kronisk bekkensmerte og tetteeggledere
AU2317600A (en) Pressure-pulse therapy apparatus for treatment of tissue
NO991278D0 (no) FremgangsmÕte og system for sikker, direktekoplet handel
AU3896900A (en) Treatment of pain
IL130171A0 (en) Therapeutic use of melatonin
NO20021947L (no) Bio-b¶rende matrikser, fremgangsmåte for fremstilling og anvendelse derav
HK1048441A1 (en) Drug for treating fractures
DK1178981T3 (da) Substituerede 3-pyridyl-4-arylpyrroler og deres terapeutiske og profylaktiske anvendelser
AU1962801A (en) Device for treatment of spider veins
NO20022990L (no) Fremgangsmåte og sammensetning for behandling av smerte
IS6427A (is) Efnasamband og aðferð til að meðhöndla sársauka
NO20022482L (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
SI1303306T1 (sl) Kombinacijska terapija z epoksi-steroidnim aldosteronskim antagonistom in betaadrenergicnim antagonistom za zdravljenje kongestivne srcne odpovedi
NO20003603D0 (no) Middel for helbredelse av ødelagt vev
DK1047668T3 (da) Triazepinoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees